The national talk is over! Pfizer Paxlovid did not talk about success, and azvudine and lung cleansing detoxification granules entered medical insurance

On the last day of medical insurance negotiations (January 8), the weather was clear, the lowest temperature was -6 °C, and the negotiators of enterprises waiting outside to enter the market were significantly less than in previous days, and at about 8:25, negotiators from major enterprises entered one after another, including Tasly, Simcere, Fangsheng Pharmaceutical, Haosen, etc
.

At 9:03 a.
m.
, some negotiators walked out of the venue after the first round of quotations to communicate with colleagues on the phone, guessing the quotations of other companies in the same category and discussing their own second round of reduction, etc.
, and hung up the phone in about 5 minutes and hurriedly returned
.

The second day of medical insurance negotiations began non-exclusive bidding, and on the last day, negotiations and bidding began at the same time, and on-site observation found that among the enterprises entering today, there was a significant increase
in traditional Chinese medicine enterprises.

At 9:19, the first batch of pharmaceutical companies to complete the negotiations walked out of the venue
.
Judging from the time it takes for enterprise negotiators to enter and exit in recent days, the fast talk is generally about 20 minutes
.

(January 8, 9:19 a.
m.
The first negotiators to walk out of the venue |.
) Photo by Cyborg Blue)

Outside the venue, a number of pharmaceutical companies who came to pick up the negotiators repeatedly tiptoed to look at the venue building, and the staff from two different pharmaceutical companies talked, "There was no movement, not even a personal shadow
.
" "It means that the conversation is very intense, and it is falling a dime a dime
.
"

At 9:57, Chia Tai Tianqing walked out of the conference center
.
According to the list of varieties that have passed the formal review previously released by the National Medical Insurance Administration, Chia Tai Tianqing Pharmaceutical Group has three products, namely fulvestrant injection, zoledronic acid injection, and anlotinib hydrochloride capsules; Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical has a product, lenalidomide capsules
.

At 10:01, the negotiators of Simcere Pharmaceutical walked out of the conference center, and Nanjing Simcere TECO Pharmaceutical has a product that passed the formal review of the National Newspaper Bureau, which is a concentrated solution
for edaravone dextronicol injection.

10:34 When asked whether the price reduction was expected, one of the representatives smiled and replied: "The expectation was not met
.
" ”

Hunan Sheng Pharmaceutical has a product that has passed the formal review of the National Medical Insurance Administration, which is a cough granule
for children's Jingxing.

It is reported that Hunan Sheng Pharmaceutical's pediatric Jingxing cough granules have been selected into the "Hunan Province New Coronary Pneumonia Traditional Chinese Medicine Prevention and Treatment Plan (2022 Second Edition)"
.

A few days ago, the National Health Insurance Administration issued the "2022 National Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance Drug Catalog Adjustment Work Plan", 6 types of drugs are expected to be included, focusing on supporting rare diseases and children's drugs
.

In the field of this medical insurance negotiation, it can be seen that there are many pediatric drug companies coming to negotiate, and children's medicine is more likely to face a favorable pattern
of medical insurance and basic drugs in the future.

03 A large number of traditional Chinese medicines were negotiated, and the negotiation of lung cleansing and detoxification granules was successful